Regeneron Pharmaceuticals
REGN
#226
Rank
A$128.32 B
Marketcap
$1,168
Share price
2.09%
Change (1 day)
-8.06%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $58.96. In 2022 the company made an earnings per share (EPS) of $63.94 a decrease over its 2021 EPS that were of $120.64.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-12.05%
2022$63.94-47%
2021$120.64133.36%
2020$51.7069.13%
2019$30.57-14.44%
2018$35.73100.71%
2017$17.8031.78%
2016$13.5138.96%
2015$9.7272.55%
2014$5.63-17.55%
2013$6.83-44.98%
2012$12.42-422.54%
2011-$3.8592.13%
2010-$2.0049.41%
2009-$1.34-15.84%
2008-$1.59-36.88%
2007-$2.52-9.6%
2006-$2.794.12%
2005-$2.68-323.68%
2004$1.20-135.51%
2003-$3.38-24.38%
2002-$4.4756.35%
2001-$2.86187.3%
2000-$0.99-16%
1999-$1.18177.78%
1998-$0.43-35.71%
1997-$0.66-68.42%
1996-$2.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.33-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.49-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.13-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.23-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.90-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.02-91.49%๐Ÿ‡ซ๐Ÿ‡ท France